Axem Neurotechnology Inc.

Home stroke rehabilitation powered by digital health and neurotechnology.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Halifax, NS, Canada
  • Currency USD
  • Founded June 2016
  • Employees 7
  • Incorporation Type C-corp
  • Website axemneuro.com

Company Summary

Axem enhances stroke rehabilitation using neurotechnology. Axem's proprietary system consists of software guided rehabilitation paired with a mobile functional neuroimaging device to promote brain activity patterns that drive recovery. Axem has established proof of concept, validated its reimbursement model with payers, met with FDA to determine regulatory path to access $5.8B US TAM, and is currently seeking seed-stage investors.

Team

  • Co-Founder & CEO

    Tony is a physical therapist with years of experience working with patients recovering from stroke and other types of neurological afflictions. He has a MSc in Kinesiology and is a current PhD candidate in Psychology and Neuroscience. He has published peer-reviewed papers in the areas of motor learning, exercise physiology and neurorehabilitation. Tony is also a serial entrepreneur having co-founded an award-winning dance company.

  • Christopher Friesen
    Co-Founder & CTO

    Christopher is a PhD candidate with experience designing and building brain-computer-interface systems. He has a MSc (also in Psychology/Neuroscience) and has published peer-reviewed papers and abstracts in the areas of brain-computer-interface design, neurorehabilitation, and functional near-infrared spectroscopy (fNIRS) development.

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free